Projects per year
Personal profile
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Liz Pluhar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigation of mechanisms of resistance to immunotherapy in dogs with spontaneous high-grade glioma
Arnold, S. A., Olin, M. R. & Pluhar, L.
3/1/21 → 2/28/22
Project: Research project
-
Elucidating the immunosuppressive mechanism(s) of tumor vascular endothelial cells to develop immunotherapy for CNS tumors
Pluhar, L., Arnold, S. A. & Olin, M. R.
V FOUNDATION FOR CANCER RESEARCH
1/15/21 → 1/15/23
Project: Research project
-
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
Pluhar, L., Arnold, S. A., O'Sullivan, G. & Olin, M. R.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/20 → 8/31/22
Project: Research project
-
Optimizing skin-implant interface of osseointegrated dev
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
10/1/17 → 9/30/21
Project: Research project
-
Evaluating the safety of the tumor monorail in a companion animal model
Pluhar, L., Arnold, S. A. & Lawrence, J.
7/1/20 → 6/30/21
Project: Research project
-
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
Ampudia-Mesias, E., Puerta-Martinez, F., Bridges, M., Zellmer, D., Janeiro, A., Strokes, M., Sham, Y. Y., Taher, A., Castro, M., Moertel, C. L., Pluhar, G. E. & Olin, M. R., 2021, (Accepted/In press) In: Neurotherapeutics.Research output: Contribution to journal › Article › peer-review
-
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway (Neurotherapeutics, (2021), 10.1007/s13311-021-01038-1)
Ampudia-Mesias, E., Puerta-Martinez, F., Bridges, M., Zellmer, D., Janeiro, A., Strokes, M., Sham, Y. Y., Taher, A., Castro, M. G., Moertel, C. L., Pluhar, G. E. & Olin, M. R., 2021, (Accepted/In press) In: Neurotherapeutics.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
CD200 checkpoint reversal: A novel approach to immunotherapy a C
Xiong, Z., Mesias, E. A., Elizabeth Pluhar, G., Rathe, S. K., Largaespada, D. A., Sham, Y. Y., Moertel, C. L. & Olin, M. R., Jan 1 2020, In: Clinical Cancer Research. 26, 1, p. 232-241 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Development of a Novel Canine Model of Ischemic Stroke: Skull Base Approach with Transient Middle Cerebral Artery Occlusion
Vasquez, C. A., Moen, S. L., Juliano, M. J., Jagadeesan, B. D., Pluhar, G. E., Chen, C. C. & Grande, A. W., Jul 2019, In: World neurosurgery. 127, p. e251-e260Research output: Contribution to journal › Article › peer-review
-
Oligodendroglioma with Neuronal Differentiation in Two Boxer Dogs
Cornax, I., Pluhar, G. E., Clark, H. B. & O'Sullivan, M. G., Oct 2019, In: Journal of Comparative Pathology. 172, p. 11-16 6 p.Research output: Contribution to journal › Article › peer-review